CRYOcheck Chromogenic Factor VIII is for clinical laboratory use in the quantita
CRYOcheck Chromogenic Factor VIII is for clinical laboratory use in the quantitative determination of factor VIII activity in 3.2% citrated human plasma. It is intended to be used in identifying factor VIII deficiency and as an aid in the management of hemophilia A in individuals aged 2 years and older. For in vitro diagnostic use
The CRYOcheck FVIII Inhibitor Kit is for clinical laboratory use in conjunction
The CRYOcheck FVIII Inhibitor Kit is for clinical laboratory use in conjunction with a factor VIII activity assay to enable performance of a modified Nijmegen-Bethesda assay using 3.2% citrated human plasma. It enables the determination of a functional FVIII inhibitor titer to aid in the clinical management of congenital hemophilia A in individuals aged 2 years and older.
For the quantitative determination of free protein S antigen in human plasma col
For the quantitative determination of free protein S antigen in human plasma collected from venous blood samplesin 3.2 % sodium citrate tubes on the BCS XP System, the SYSMEX CS-2500 analyzer and the SYSMEX CS-5100 analyzer.
Determination of ristocetin co-factor activity of von Willebrand factor in human
Determination of ristocetin co-factor activity of von Willebrand factor in human plasma through platelet agglutination
Quantative determination of protein C activity as an aid in the diagnosis of inh
Quantative determination of protein C activity as an aid in the diagnosis of inherited and acquired deficiencies
Quantative determination of protein C activity as an aid in the diagnosis of inh
Quantative determination of protein C activity as an aid in the diagnosis of inherited and acquired deficiencies
Quantative determination of a2-antiplasmin activity as an aid in the diagnosis o
Quantative determination of a2-antiplasmin activity as an aid in the diagnosis of inherited or acquired deficiencies and in management of fibrinolytic therapy
The Factor VIII Antibody Screen is a qualitative solid phase enzyme linked immun
The Factor VIII Antibody Screen is a qualitative solid phase enzyme linked immunosorbent assay (ELISA) designed to detect reactive with recombinant human factor VIII (FVIII) in human serum and plasma.